Trickle Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (505)	3/24/2001 11:40:31 AM
From: tuck	of 1784

Interesting article from Drug Discovery & Development about Abbott's internal lab automation program. Some things they make are specific to Abbott's efforts; trickle companies would not make any money developing such things. Others clearly could be commercialized. Indeed, as noted a while ago, their uARCS HTS system has been licensed to the latest Trickle portfolio holding, Discovery Partners International. I could see their system for x-ray crystallography sample prep and automation being commercialized, too, and perhaps others. dddmag.com Also from the same folks, an article about Millipore's new plastic that keeps analytes from sticking to the dialysis equipment (thus throwing off results of serum protein binding studies). MIL is soon to be a trickle company due to its impending split with the microelectronics division. dddmag.com Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next